Abiopharma

🔍 Laponis Adam (Executive)

Company: Twist Bioscience Corp (TWST)

Report Date: 2026-01-09

Detailed Transactions and Holdings:

• Sold 2,738 shares of Common Stock at $35.261 per share (Direct)
  Date: 2026-01-09 | Code: S | equity_swap_involved: false | shares_owned_after: 140,031.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.